STSA-1301
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for STSA-1301, covering 2024-08-12 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP) [Phase 1, Phase 2]